Hyperamylasemia - is it always pancreatitis?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The differential diagnosis of diseases leading to hyperamylasemia is extensive and diverse, and pancreatitis is the first disease that needs to be excluded. Most often, acute pancreatitis and/or exacerbation of chronic pancreatitis lead to hyperamylasemia, which is accompanied by hyperamylasuria (increased urine diastase) and specific symptom complex with pain playing a key role. Thereby, many doctors most often diagnose pancreatitis in case of a combination of abdominal pain and hyperamylasemia. Is this diagnosis always valid? The presented clinical case of hyperamylasemia in a patient with celiac disease demonstrates the variability of diseases involving hyperamylasemia, and shows how important it is to determine its cause in time and accurately.

Full Text

Restricted Access

About the authors

Karine A. Nikolskaya

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

Email: k.nikolskaya@mknc.ru
PhD, Senior Researcher at the Department of Pathology of the Pancreas and Biliary Tract

D. S Bordin

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department; Tver State Medical University

L. V Vinokurova

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

M. V Malykh

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

E. A Dubtsova

A.S. Loginov Moscow Clinical Scientific Center of the Moscow Healthcare Department

References

  1. Тихонова Т.А. Гиперамилаземия - угрожающий симптом или безопасная находка? Бюллетень медицинских интернет-конференций. 2016;6(6).
  2. Красновский А.Л., Григорьев С.П., Золкина И.В. и др. Бессимптомная панкреатическая гиперферментемия. Российский медицинский журнал. 2014;5:52-56.
  3. Logie J.J., Cox M., Sharkey J. A multidisciplinary approach to an unusual cause of hyperamylasaemia. BMJ CaseRep. 2015;6:2015209780. doi: 10.1136/bcr-2015-209780.
  4. Shah K.S., Shelat V.G., Jogai S., Trompetas V. Primary gallbladder lymphoma presenting with perforated cholecystitis and hyperamylasaemia. Ann R. CollSurg Engl. 2016;98(2):13-5. Doi: 10.1308/ rcsann.2016.0001.
  5. Sinha S., Khan H., Timms P.M., Olagbaiye O.A. Pancreatic-type hyperamylasemia and hyperlipasemia secondary to ruptured ovarian cyst: a case report and review of the literature. J. EmergMed. 2010;38(4):463-66. Doi: 10.1016/j. jemermed.2008.04.042.
  6. Matsuura H., et al. Four cases of macroamylasemia malignant tumor. Bull Hygo Cancer Hosp. 1981;12:59.
  7. Wilding P., Cooke W.T., Nicholson G.I. Globulin-bound amylase. Ann. Intern. Med. 1964;64: 1053-56.
  8. Berk J.E., Kizu H., Wilding P., Searcy R.L. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N. Engl J. Med. 1967;277:941-46.
  9. Губергриц Н.Б., Лукашевич Г.М., Загоренко Ю.А. Макроамилаземия - безобидное заблуждение или опасное незнание? Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2007;5:64-70.
  10. Levitt M.D. Study of macroamylase complexes. J. Lab Clin Med. 1972;80:414-22.
  11. Haubrich W.S., Schaffner F., Berk J.E. Macroamylasemia. Bockus gastroenterology. 5th ed. Philadelphia: WB Saunders, 1995. P. 2851-60.
  12. Губергиц Н.Б., Голубова О.А. Макроамилаземия у больных с хроническим панкреатитом. Вопросы реконструктивной и пластической хирургии. 2014;1(48):75-80.
  13. Imrie C.W., King J., Henderson A.R. Macroamylasemiae survey of prevalence in a mixed population. N. Engl J. Med. 1972;287-931.
  14. Barrows D., Berk J.E., Fridhandler L. Macroamylasemiae survey of prevalence in a mixed population. N. Engl J. Med. 1972;286:1352.
  15. Berk J.E., Fridhandler L. The prevalence of macroamylasemia. Further study. Am J. Gastroenterol 1974;62:54-8.
  16. Boyle C.E.L., Fraser C.G. Macroamylasaemia: how common is it? Br Med J. 1985;291;1389.
  17. Gubergrits N., Golubova O., Lukashevich G., Fomenko P. Elevated serum amylase in patients with chronic pancreatitis: Acute attack or macroamylasemia? Pancreatology. 2014;14:114-16. Doi: 10.1016/j. pan.2013.12.004.
  18. Forsman R.W. Macroamylase:Prevalence,distribution of age, sex, amylase activity, and electrophoretic mobility. Clin Biochem. 1986;19:250-53.
  19. Warshaw A.L., Hawboldt M.M. Puzzling persistent hyperamylasemia, probably neither pancreatic nor pathologic. Am J. Surg. 1988;155:453-56.
  20. Губергриц Н.Б., Лукашевич Г.М., Загоренко Ю.А. Макроамилаземия - безобидное заблуждение или опасное незнание? Сучасна гастроентерологія. 2006;6(32):93.
  21. Mifflin T.E., Benjamin D.C., Bruns D.E. Rapid quantitative, specific measurement of pancreatic amylase in serum with use of a monoclonal antibody. Clin Chem. 1985;31(8): 1283-88.
  22. Mifflin T.E., Forsman R.W., Bruns D.E. Interaction of immobilized anti-salivary amylase antibody with human macroamylases: implications for use in a pancreatic amylase assay to distinguish macroamylasemia from acute pancreatitis. Clin Chem. 1989;35:1651-54.
  23. Iatt J. A., Ellison E.C. Amylase assay and diagnosis of pancreatic disease [Editorial]. Clin Chem. 1985;31:1263.
  24. Anunann R.W., Berk J.E., Fridhandler L., et al. Hyperamylasemia with carcinoma of the lung. Ann Intern Med. 1973;78:521-25.
  25. Warshaw A.L., Lee K.H. Characteristic alterations of serum isoenzymesofamylase in diseasesofliver, pancreas,salivarygland,lung, and genitals. J. Surg Res. 1977;22:362-69.
  26. Gao T., Eto K., Nakayama J., et al. Abnormalamylasein a patient with malignant tumor. Med Biol (Tokyo). 1971;82:53-6.
  27. Ishizuka T., Yasuda K., Kajita K., et al. Macroamylasemiaassociated with thyroid cancer, elevated serum thyroxine-binding globulin(TBG),chronic pancreatitis, and gastrointestinal polyposis. Gastroenterol Jpn. 1986;21:385-90.
  28. Blumstein M., Bank S., Greenberg R.E., et al. Immunoproliferative small intestinal disease in an American patient with lymphoma and macroamylasemia. Gastroenterology. 1992;103(3):1071-74.
  29. Katsanos K.H., Kolios G., Tsianos G.V., Tsianos E.V. Hyperamylasemia in inflammatory bowel disease: report of a case with literature review. Ann Gastroenterol. 2004;17(3):306-12.
  30. Katz S., Bank S., Greenberg R.E., et al. Hyperamy lasemia in inflammatory bowel disease. J. Clin Gastroenterol. 1988;10(6):627-30.
  31. Rabsztyn A., Green P.H.R., Berti I., et al. Macroamylasemia in patients with coeliac disease. Am J. Gastroenterol. 2001;96:1096-100.
  32. Carroccio A., Di Prima L., Scalici C., et al. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease. Clin Gastroenterol Hepatol. 2006;4(4):455-59.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies